Characteristics and Outcomes of Critically Ill Trauma Patients in Australia and New Zealand (2005-2017).


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 29 2 2020
medline: 20 5 2021
entrez: 29 2 2020
Statut: ppublish

Résumé

To compare the characteristics of adults admitted to the ICU in Australia and New Zealand after trauma with nonelective, nontrauma admissions. To describe trends in hospital mortality and rates of discharge home among these two groups. Retrospective review (2005-2017) of the Australia and New Zealand Intensive Care Society's Center for Outcome and Resource Evaluation Adult Patient Database. Adult ICUs in Australia and New Zealand. Adult (≥17 yr), nonelective, ICU admissions. Observational study. We compared 77,002 trauma with 741,829 nonelective, nontrauma patients. Trauma patients were younger (49.0 ± 21.6 vs 60.6 ± 18.7 yr; p < 0.0001), predominantly male (73.1% vs 53.9%; p < 0.0001), and more frequently treated in tertiary hospitals (74.7% vs 45.8%; p < 0.0001). The mean age of trauma patients increased over time but was virtually static for nonelective, nontrauma patients (0.72 ± 0.02 yr/yr vs 0.03 ± 0.01 yr/yr; p < 0.0001). Illness severity increased for trauma but fell for nonelective, nontrauma patients (mean Australia and New Zealand risk of death: 0.10% ± 0.02%/yr vs -0.21% ± 0.01%/yr; p < 0.0001). Trauma patients had a lower hospital mortality than nonelective, nontrauma patients (10.0% vs 15.8%; p < 0.0001). Both groups showed an annual decline in the illness severity adjusted odds ratio (odds ratio) of hospital mortality, but this was slower among trauma patients (trauma: odds ratio 0.976/yr [0.968-0.984/yr; p < 0.0001]; nonelective, nontrauma: odds ratio 0.957/yr [0.955-0.959/yr; p < 0.0001]; interaction p < 0.0001). Trauma patients had lower rates of discharge home than nonelective, nontrauma patients (56.7% vs 64.6%; p < 0.0001). There was an annual decline in illness severity adjusted odds ratio of discharge home among trauma patients, whereas nonelective, nontrauma patients displayed an annual increase (trauma: odds ratio 0.986/yr [0.981-0.990/yr; p < 0.0001]; nonelective, nontrauma: odds ratio 1.014/yr [1.012-1.016/yr; p < 0.0001]; interaction: p < 0.0001). The age and illness severity of adult ICU trauma patients in Australia and New Zealand has increased over time. Hospital mortality is lower for trauma than other nonelective ICU patients but has fallen more slowly. Trauma patients have become less likely to be discharged home than other nonelective ICU patients.

Identifiants

pubmed: 32108705
doi: 10.1097/CCM.0000000000004284
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

717-724

Auteurs

Anthony J Wilson (AJ)

Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
Adult Critical Care, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.

Fraser Magee (F)

Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.

Michael Bailey (M)

Australian and New Zealand Intensive Care Research Centre (ANZIC RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Department of Medicine and Radiology, University of Melbourne, Melbourne, VIC, Australia.

David V Pilcher (DV)

Australian and New Zealand Intensive Care Research Centre (ANZIC RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Department of Intensive Care and Hyperbaric Medicine, The Alfred, Commercial Road, Melbourne, VIC, Australia.
The Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcome and Resource Evaluation (CORE), Camberwell, VIC, Australia.

Craig French (C)

Department of Intensive Care, Western Health, Melbourne, VIC, Australia.

Alistair Nichol (A)

Australian and New Zealand Intensive Care Research Centre (ANZIC RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Department of Intensive Care and Hyperbaric Medicine, The Alfred, Commercial Road, Melbourne, VIC, Australia.
Clinical Research Centre, School of Medicine, University College Dublin, Dublin, Ireland.

Andrew Udy (A)

Australian and New Zealand Intensive Care Research Centre (ANZIC RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Department of Intensive Care and Hyperbaric Medicine, The Alfred, Commercial Road, Melbourne, VIC, Australia.

Carol L Hodgson (CL)

Australian and New Zealand Intensive Care Research Centre (ANZIC RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

D James Cooper (DJ)

Australian and New Zealand Intensive Care Research Centre (ANZIC RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Department of Intensive Care and Hyperbaric Medicine, The Alfred, Commercial Road, Melbourne, VIC, Australia.

Michael C Reade (MC)

Australian and New Zealand Intensive Care Research Centre (ANZIC RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Joint Health Command, Australian Defense Force, Canberra, ACT, Australia.

Paul Young (P)

Medical Research Institute of New Zealand, Wellington, New Zealand.
Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.

Rinaldo Bellomo (R)

Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
Australian and New Zealand Intensive Care Research Centre (ANZIC RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
School of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Clinical Research Centre, School of Medicine, University College Dublin, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH